Treating Dry Eye Disease: Moving Beyond the Barriers With New Options

Author(s)/Faculty: Edward J. Holland, MD; Marjan Farid, MD; Preeya K. Gupta, MD; Francis S. Mah, MD
Release Date: 3/10/2022Expiration Date: 3/10/2023
Credit Type: CME / CME with ABO Continuing Certification Number of Credits: 1.25
Content Type: MonographProvider:
Dry eye disease (DED) is highly prevalent but frequently underdiagnosed and undertreated. DED has a significant impact on patient employment and other activities. Although some risk factors, such as smoking and excessive screen time, are well known, numerous additional risk factors and associations with comorbidities are now considered. While traditional therapies for DED may be helpful, the need for more effective treatments remains. New treatments for DED, with novel mechanisms of action, have become available. In this CME activity, experts in the field will explore the mechanisms of action for conventional versus novel therapies as well the efficacy and safety of new therapies for their ability to treat both the signs and symptoms of DED.